BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27022279)

  • 1. The role of semaphorin 4D as a potential biomarker for antiangiogenic therapy in colorectal cancer.
    Ding X; Qiu L; Zhang L; Xi J; Li D; Huang X; Zhao Y; Wang X; Sun Q
    Onco Targets Ther; 2016; 9():1189-204. PubMed ID: 27022279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of semaphorin 4D in tumor development and angiogenesis in human breast cancer.
    Jiang H; Chen C; Sun Q; Wu J; Qiu L; Gao C; Liu W; Yang J; Jun N; Dong J
    Onco Targets Ther; 2016; 9():5737-5750. PubMed ID: 27729799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Semaphorin 4D-Plexin-B1-RhoA signaling axis recruits pericytes and regulates vascular permeability through endothelial production of PDGF-B and ANGPTL4.
    Zhou H; Yang YH; Basile JR
    Angiogenesis; 2014 Jan; 17(1):261-74. PubMed ID: 24114199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
    Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
    Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semaphorin 4D Enhances Angiogenic Potential and Suppresses Osteo-/Odontogenic Differentiation of Human Dental Pulp Stem Cells.
    Zou T; Dissanayaka WL; Jiang S; Wang S; Heng BC; Huang X; Zhang C
    J Endod; 2017 Feb; 43(2):297-305. PubMed ID: 28027822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semaphorin 4D cooperates with VEGF to promote angiogenesis and tumor progression.
    Zhou H; Binmadi NO; Yang YH; Proia P; Basile JR
    Angiogenesis; 2012 Sep; 15(3):391-407. PubMed ID: 22476930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plexin-B1 and semaphorin 4D cooperate to promote cutaneous squamous cell carcinoma cell proliferation, migration and invasion.
    Cao J; Zhang C; Chen T; Tian R; Sun S; Yu X; Xiao C; Wang G; Liu Y; Fu M; Li W
    J Dermatol Sci; 2015 Aug; 79(2):127-36. PubMed ID: 26051877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis.
    Basile JR; Castilho RM; Williams VP; Gutkind JS
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9017-22. PubMed ID: 16754882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semaphorin 4D and hypoxia-inducible factor-1α overexpression is related to prognosis in colorectal carcinoma.
    Wang JS; Jing CQ; Shan KS; Chen YZ; Guo XB; Cao ZX; Mu LJ; Peng LP; Zhou ML; Li LP
    World J Gastroenterol; 2015 Feb; 21(7):2191-8. PubMed ID: 25717256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the Effects of Semaphorin 4D Signaling on Angiogenesis.
    Zhou H; Yang YH; Basile JR
    Methods Mol Biol; 2017; 1493():429-441. PubMed ID: 27787869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.
    Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G
    J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor Effects of Anti-Semaphorin 4D Antibody Unravel a Novel Proinvasive Mechanism of Vascular-Targeting Agents.
    Zuazo-Gaztelu I; Pàez-Ribes M; Carrasco P; Martín L; Soler A; Martínez-Lozano M; Pons R; Llena J; Palomero L; Graupera M; Casanovas O
    Cancer Res; 2019 Oct; 79(20):5328-5341. PubMed ID: 31239269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Semaphorin 4D in Bone Remodeling and Cancer Metastasis.
    Lontos K; Adamik J; Tsagianni A; Galson DL; Chirgwin JM; Suvannasankha A
    Front Endocrinol (Lausanne); 2018; 9():322. PubMed ID: 29971044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
    Ding C; Li L; Yang T; Fan X; Wu G
    BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis in primary colorectal cancer and matched metastatic tissues: Biological and clinical implications for anti-angiogenic therapies.
    Yin L; Li J; Ma D; Li D; Sun Y
    Oncol Lett; 2020 May; 19(5):3558-3566. PubMed ID: 32269630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semaphorin 4D promotes the proliferation and metastasis of bladder cancer by activating the PI3K/AKT pathway.
    Lu JJ; Su YW; Wang CJ; Li DF; Zhou L
    Tumori; 2019 Jun; 105(3):231-242. PubMed ID: 30674231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semaphoring 4D is required for the induction of antioxidant stress and anti-inflammatory effects of dihydromyricetin in colon cancer.
    Liang J; Wu J; Wang F; Zhang P; Zhang X
    Int Immunopharmacol; 2019 Feb; 67():220-230. PubMed ID: 30562683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications.
    Yoshida Y; Ogata A; Kang S; Ebina K; Shi K; Nojima S; Kimura T; Ito D; Morimoto K; Nishide M; Hosokawa T; Hirano T; Shima Y; Narazaki M; Tsuboi H; Saeki Y; Tomita T; Tanaka T; Kumanogoh A
    Arthritis Rheumatol; 2015 Jun; 67(6):1481-90. PubMed ID: 25707877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies.
    Evans EE; Jonason AS; Bussler H; Torno S; Veeraraghavan J; Reilly C; Doherty MA; Seils J; Winter LA; Mallow C; Kirk R; Howell A; Giralico S; Scrivens M; Klimatcheva K; Fisher TL; Bowers WJ; Paris M; Smith ES; Zauderer M
    Cancer Immunol Res; 2015 Jun; 3(6):689-701. PubMed ID: 25614511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.